| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.4 | 0.009 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.32 | 0.01 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |